The global dental bone graft substitutes market is expected to reach USD 664.3 million by 2021, at a CAGR of 9.8% from 2016 to 2021.
The shift from autografts to allografts and further penetration of synthetic & tissue engineered bone grafts due to the technological advancements in the market are propelling the growth of dental bone graft substitutes market. Moreover, increasing demand from customers, rising inclination towards cosmetic dentistry, and growing industry standards are also spurring the growth of this market. However, unfavorable reimbursement scenarios in some countries are hampering the growth of this market.
Using patient's own bone has traditionally been the most preferred method of bone grafting; however, increasing technological advancements have increased the number of synthetic graft options. The benefits of synthetic grafts include availability, sterility, and reduced morbidity. Also, the synthetic bone grafts have a longer shelf life and there is no risk of any disease. Because of these benefits, synthetic bone graft is the fastest-growing type in the dental bone graft substitutes market.
The European region is estimated to account for the largest share of the dental bone graft substitutes market in 2016. As implant dentistry originated in the European region, the penetration rate of dental bone graft substitutes is very high in this region. The main factors driving the growth of the Europe market are the continuous increase in aging population, governmental expenditure on oral healthcare across the region, and the high reimbursement rate although limited to Germany, Sweden, and the Netherlands.
Biohorizons Iph, Inc.
Dentsply Sirona International
Geistlich Pharma Ag
Institut Straumann Ag
Rti Surgical, Inc.
Zimmer Holding Inc
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Dental Bone Graft Substitutes Market, By Type
7 Global Dental Bone Graft Substitutes Market, By Application